Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
1.50
0.28 (22.95%)
At close: Sep 26, 2025, 3:59 PM
1.53
2.00%
After-hours: Sep 26, 2025, 07:09 PM EDT
Prelude Therapeutics Revenue
Prelude Therapeutics reported an annual revenue of $7M, reflecting a 0% growth. For the quarter ending June 30, 2025, Prelude Therapeutics generated $0 in revenue.
Revenue (ttm)
7M
Revenue Growth
n/a
Price / Sales Ratio
13.75
Revenue / Employee
53.44K
Employees
131
Market Cap
82.78M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 7M | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |